Literature DB >> 17037557

Coronavirus immunity: from T cells to B cells.

Cornelia C Bergmann1, Chandran Ramakrishna, J M Gonzales, S I Tschen, Stephan A Stohlman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17037557      PMCID: PMC7124054          DOI: 10.1007/978-0-387-33012-9_61

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  60 in total

1.  Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system.

Authors:  C C Bergmann; J D Altman; D Hinton; S A Stohlman
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

2.  Antibody is required for clearance of infectious murine hepatitis virus A59 from the central nervous system, but not the liver.

Authors:  A E Matthews; S R Weiss; M J Shlomchik; L G Hannum; J L Gombold; Y Paterson
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

Review 3.  T cell immunity in lymphoid and non-lymphoid tissues.

Authors:  Leo Lefrançois; David Masopust
Journal:  Curr Opin Immunol       Date:  2002-08       Impact factor: 7.486

4.  Selection of CD8+ T cells with highly focused specificity during viral persistence in the central nervous system.

Authors:  N W Marten; S A Stohlman; W Smith-Begolka; S D Miller; E Dimacali; Q Yao; S Stohl; J Goverman; C C Bergmann
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

5.  Antibody prevents virus reactivation within the central nervous system.

Authors:  M T Lin; D R Hinton; N W Marten; C C Bergmann; S A Stohlman
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

6.  CTL effector function within the central nervous system requires CD4+ T cells.

Authors:  S A Stohlman; C C Bergmann; M T Lin; D J Cua; D R Hinton
Journal:  J Immunol       Date:  1998-03-15       Impact factor: 5.422

7.  Rebuilding an immune-mediated central nervous system disease: weighing the pathogenicity of antigen-specific versus bystander T cells.

Authors:  Dorian B McGavern; Phi Truong
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

8.  Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination.

Authors:  F I Wang; D R Hinton; W Gilmore; M D Trousdale; J O Fleming
Journal:  Lab Invest       Date:  1992-06       Impact factor: 5.662

9.  Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis.

Authors:  William G Glass; Michelle J Hickey; Jenny L Hardison; Michael T Liu; Jerry E Manning; Thomas E Lane
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

Review 10.  Immune responses to RNA-virus infections of the CNS.

Authors:  Diane E Griffin
Journal:  Nat Rev Immunol       Date:  2003-06       Impact factor: 53.106

View more
  2 in total

1.  T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissue.

Authors:  Samantha R Stubblefield Park; Mi Widness; Alan D Levine; Catherine E Patterson
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

Review 2.  A contemporary review on pathogenesis and immunity of COVID-19 infection.

Authors:  Rasoul Mirzaei; Sajad Karampoor; Mohammad Sholeh; Pouya Moradi; Reza Ranjbar; Faezeh Ghasemi
Journal:  Mol Biol Rep       Date:  2020-06-29       Impact factor: 2.316

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.